The image shows EGFR (pink) and DAPI (nuclei in blue) of EGFR-expressing A431 xenografts obtained from mice administered with lovastatin. Lovastatin enhances temporary EGFR availability at the cell membrane of tumor cells. For details, see the article by Pereira and colleagues on page 6215 of this issue.